70.22.Z - Head office activities and management consultancy
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
70.10.Z - Head office activities
70.21.Z - Head office activities and management consultancy
73.11.Z - Advertising agency activities
82.99.Z - Other business support activities, not elsewhere classified
84.12.Z - Management of public services in health, education, culture, and other social services
85.60.Z - Educational support activities
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | 101,7 | -528,5 | -403,8 | 23,6 |
Gross profit (loss) | 222,4 | -595,8 | -449 | 24,6 |
EBITDA | -528,5 | -403,8 | 23,6 | |
Short time liabilities | 52,4 | 28,1 | 9,1 | -67,7 |
Other operating costs | 0 | 0 | 0 | -53,3 |
Equity capital | 291,8 | 235,7 | 190,5 | -19,2 |
Operating profit (EBIT) | 101,7 | -528,5 | -403,8 | 23,6 |
Assets | 349,9 | 263,9 | 199,6 | -24,3 |
Net profit (loss) | 211,6 | -539,7 | -403,8 | 25,2 |
Cash | 177,3 | 0 | 0 | 0 |
Net income from sale | 464,4 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 58,1 | 28,1 | 9,1 | -67,7 |
Working assets | 349,9 | 263,9 | 199,6 | -24,3 |
Other income costs | 0 | 0 | 0 | -78,9 |
Depreciation | 0 | 0 | 0 | |
% | % | % | p.p. | |
Profitability of capital | 72,5 | -229 | -211,9 | 17,1 |
Equity capital to total assets | 83,4 | 89,3 | 95,5 | 6,2 |
Gross profit margin | 47,9 | 23,5 | ||
EBITDA Margin | -16,9 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 41 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 6.670649528503418 | 9.377289772033691 | 21.98993682861328 | 12,6 |
Net dept to EBITDA | 0 | 0 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane